Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Yoko Omoto"'
Autor:
Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Mai Tomiguchi, Keiichi Murakami, Yoko Omoto, Hirotaka Iwase
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background ESR1 mutations have attracted attention as a potentially important marker and treatment target in endocrine therapy-resistant breast cancer patients. The E380Q mutation, which is one of the ESR1 mutations, is associated with estra
Externí odkaz:
https://doaj.org/article/580f7920044e4ef88faff899288a3722
Autor:
Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Aiko Sueta, Keiichi Murakami, Yoko Omoto, Hirotaka Iwase
Publikováno v:
Translational Oncology, Vol 10, Iss 5, Pp 766-771 (2017)
BACKGROUND: ESR1 mutation in circulating cell-free DNA (cfDNA) is emerging as a noninvasive biomarker of acquired resistance to endocrine therapy, but there is a paucity of data comparing the status of ESR1 gene in cfDNA with that in its correspondin
Externí odkaz:
https://doaj.org/article/02056249fdb041ca9df4e5f943f41eb6
Autor:
Marko Matic, Galyna Bryzgalova, Hui Gao, Per Antonson, Patricia Humire, Yoko Omoto, Neil Portwood, Camilla Pramfalk, Suad Efendic, Per-Olof Berggren, Jan-Åke Gustafsson, Karin Dahlman-Wright
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217526 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0057458.].
Externí odkaz:
https://doaj.org/article/78b26e0457114b85a3e8efa161028abe
Autor:
Takashi Takeshita, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Yoko Omoto, Yumi Honda, Ken-ichi Iyama, Zhenhuan Zhang, Hirotaka Iwase
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80552 (2013)
Pax transactivation domain interacting protein (PTIP) associated protein 1, PA1, was a newly found protein participating in the modulation of transactivity of nuclear receptor super family members such as estrogen receptor (ER), androgen receptor (AR
Externí odkaz:
https://doaj.org/article/05d19c7c82904aae9b1437d797aa7a45
Autor:
Marko Matic, Galyna Bryzgalova, Hui Gao, Per Antonson, Patricia Humire, Yoko Omoto, Neil Portwood, Camilla Pramfalk, Suad Efendic, Per-Olof Berggren, Jan-Åke Gustafsson, Karin Dahlman-Wright
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57458 (2013)
An increasing body of evidence now links estrogenic signalling with the metabolic syndrome (MS). Despite the beneficial estrogenic effects in reversing some of the MS symptoms, the underlying mechanisms remain largely undiscovered. We have previously
Externí odkaz:
https://doaj.org/article/78c9ceb9069a42e8ae141228c6a11656
Autor:
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Mai Tomiguchi, Keiichi Murakami, Hirotaka Iwase, Yoko Omoto, Aiko Sueta, Takashi Takeshita
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Cancer
BMC Cancer
Background ESR1 mutations have attracted attention as a potentially important marker and treatment target in endocrine therapy-resistant breast cancer patients. The E380Q mutation, which is one of the ESR1 mutations, is associated with estradiol (E2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb6828690d2c9dcbec6b540ea52832f
http://link.springer.com/article/10.1186/s12885-017-3779-2
http://link.springer.com/article/10.1186/s12885-017-3779-2
Autor:
Mai Tomiguchi, Yutaka Yamamoto, Yoko Omoto, Keiichi Murakami, Mutsuko Yamamoto-Ibusuki, Takashi Takeshita, Hirotaka Iwase, Aiko Sueta
Publikováno v:
Oncotarget. 8:52142-52155
// Takashi Takeshita 1 , Yutaka Yamamoto 1 , Mutsuko Yamamoto-Ibusuki 2 , Mai Tomiguchi 1 , Aiko Sueta 1 , Keiichi Murakami 1 , Yoko Omoto 1,3 and Hirotaka Iwase 1 1 Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d2efd48f46eaf95431af591b533bf34
https://doi.org/10.18632/oncotarget.18479
https://doi.org/10.18632/oncotarget.18479
Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
Autor:
Yoko Omoto, Per Antonson, Camilla Pramfalk, Marko Matic, Neil Portwood, Patricia Humire, Suad Efendic, Karin Dahlman-Wright, Per Olof Berggren, Hui Gao, Galyna Bryzgalova, Jan-Ake Gustafsson
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217526 (2019)
PLoS ONE
PLoS ONE
An increasing body of evidence now links estrogenic signalling with the metabolic syndrome (MS). Despite the beneficial estrogenic effects in reversing some of the MS symptoms, the underlying mechanisms remain largely undiscovered. We have previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea52506c32509708f25f714fdaccc18d
http://europepmc.org/articles/PMC6583955?pdf=render
http://europepmc.org/articles/PMC6583955?pdf=render
Autor:
Saori Fujiwara, Hirotaka Iwase, Yoko Omoto, Takashi Takeshita, Aiko Sueta, Toko Inao, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki
Publikováno v:
Oncotarget
// Takashi Takeshita 1 , Yutaka Yamamoto 1 , Mutsuko Yamamoto-Ibusuki 2 , Toko Inao 1 , Aiko Sueta 1 , Saori Fujiwara 1 , Yoko Omoto 1, 3 , Hirotaka Iwase 1 1 Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kumamoto Un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e616adc2f0123775d499df1434644232
http://europepmc.org/articles/PMC5078029
http://europepmc.org/articles/PMC5078029
Autor:
Takashi, Takeshita, Yutaka, Yamamoto, Mutsuko, Yamamoto-Ibusuki, Mai, Tomiguchi, Aiko, Sueta, Keiichi, Murakami, Yoko, Omoto, Hirotaka, Iwase
Publikováno v:
Oncotarget
Background The measurement of ESR1 and PIK3CA mutations in plasma cell-free DNA (cfDNA) has been studied as a non-invasive method to quickly assess and monitor endocrine therapy (ET) resistant metastatic breast cancer (MBC) patients. Methods The subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0819a7bf57e2e8c25e63de18ed46e4b
https://pubmed.ncbi.nlm.nih.gov/28881720
https://pubmed.ncbi.nlm.nih.gov/28881720